🚨 Join EIC Dr. Robert Gropler for a rapid overview of the May 2026 Issue of @CircImaging
🦴 PYP vs HMDP in cardiac amyloidosis
🫀 Focal vs global myocardial flow in PET
🩸 IMH location post-STEMI
🔥 Perivascular fat in AAA repair
⚖️ Sex diff in AV calc & AS outcomes
1/ New in @CircImaging: Culprit lesion location matters in STEMI. In 767 patients, circumflex (CX) infarctions showed the highest risk of intramyocardial hemorrhage (IMH) om MRI ...
1/ Higher perivascular adipose tissue (PVAT) attenuation on CTA is linked to worse outcomes after EVAR for AAA. In 275 patients, elevated PVAT predicted MACCE and aneurysm-related events, improving risk stratification - a promising imaging biomarker for ...
1/ In 8,500 patients undergoing PET MPI, diffuse impairments in myocardial perfusion are associated with poorer outcomes (MI, heart failure, mortality) compared to focal impairments and are more informative compared to global MFR. ...
In a multicenter study of patients who had clinically indicated CCTA and invasive angiography, FFRCT and DVFFR showed similar diagnostic performance characteristics for sensitivity, specificity, and AUC, compared to iFR @DineshKalra
https://t.co/dJDvH5APn8
April issue @CircImaging is here! 📢
From AI-powered detection of cardiac amyloidosis to ML-guided risk stratification & CT plaque volume, this issue highlights how #AI is transforming CV imaging - + new insights on ischemia, PET flow, imaging in pericarditis & valvular disease.
New data on PYP vs HMDP kinetics for ATTR-CM! 🫀 Both show diagnostic uptake by 10 mins. HMDP clears blood faster with higher bone uptake, accounting for appearance of delayed heart washout. Tip: Adjust windowing on delayed HMDP! #CardioTwitter#Amyloid
https://t.co/rg8WhAfwve
Aortic valve calcium (AVC) predicts long-term risk of moderate–severe aortic stenosis equally in females & males. Despite lower AVC levels in females, its prognostic value remains consistent: AVC is a key risk marker for both men & women @seamuswhelton https://t.co/YRyCaJa1aZ
1/ AI-guided CCTA quantification (AI-QCT) is refining who benefits from lipid-lowering therapy 🫀
In 2,269 symptomatic patients, higher atheroma volume (>5%) identified those with improved outcomes, even without obstructive CAD.
Personalized prevention!
#Cardiology#AI#CCTA
The American Heart Association Journals Publishing Guide is always available for download. Look for an overview of publishing policies and exciting highlights of each journal. #ACC26
Get the Pub Guide and more at the Author Hub: https://t.co/HBOGiE6gEg
Be the first to read groundbreaking research that will be unveiled at #ACC26 across the American Heart Association Journals portfolio.
Stay updated! https://t.co/ZrtuIW5fkG
The American Heart Association Journals Publishing Guide is always available for download. Look for an overview of publishing policies and exciting highlights of each journal. #ACC26
Get the Pub Guide and more at the Author Hub: https://t.co/HBOGiE6gEg